{
    "info": {
        "nct_id": "NCT05077137",
        "official_title": "A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy",
        "inclusion_criteria": "1. Histologically confirmed advanced metastatic melanoma\n2. Male or female participants who are at least 18 years of age on the day of signing informed consent\n3. Participants must be planned or scheduled by their treating physician to receive PD-1 therapy or PD-1 plus anti CTLA-4 therapy as standard of care\n4. Participant (or legally acceptable representative if applicable) provides written informed consent for the trial\n5. Participant must have at least 1 lesion that is at least 8 mm in size and is cutaneous, subcutaneous, palpable, or amenable to ultrasound guided core biopsy. The lesion chosen for biopsy can also be a target lesion but does not have to be a target lesion\n6. Adequate organ function as defined below. Standard of care labs drawn within 45 days prior to consent may be used for the purposes of determining eligibility\n\n   1. ANC >/= 1500/uL\n   2. platelets >/=100,000/uL\n   3. Hemoglobin >/= 9.0 g/dL\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Uveal or mucosal melanoma\n2. Any women known to be pregnant or breastfeeding\n3. Any prior systemic therapy for metastatic melanoma (prior surgery is allowed)\n4. Known diagnosis of immunodeficiency or receiving chronic systemic steroid therapy (in doses exceeding 10 mg daily of prednisone or equivalent), or any other form of immunosuppressive therapy within 7 days prior to first research biopsy\n5. Patients with symptomatic CNS metastases and/or carcinomatous meningitis\n\n   a) Patients with asymptomatic, stable CNS metastases are allowed provided that they are not on >10mg prednisone daily\n6. History of or active (non-infectious) pneumonitis that required steroids\n7. Active infection requiring systemic therapy\n8. Known history of Human Immunodeficiency Virus (HIV) infection\n9. Known history of Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV RNA [qualitative] is detected) infection. NOTE: no testing for Hepatitis B or Hepatitis C is required\n10. Known history of active TB (Bacillus Tuberculosis)\n11. History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with subject's participation for the full duration of the study, or make it not in the best interest of the subject to participate, in the opinion of the treating physician\n12. Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial\n13. History of allogenic tissue or solid organ transplant\n14. History of allergic reaction to IPOL or Td vaccine\n15. Receipt of Td vaccine within 30 days prior to starting IO therapy",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "1. Histologically confirmed advanced metastatic melanoma",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed",
                    "criterion": "melanoma",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histology"
                        }
                    ]
                },
                {
                    "exact_snippets": "advanced metastatic melanoma",
                    "criterion": "melanoma",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Participant (or legally acceptable representative if applicable) provides written informed consent for the trial",
            "criterions": [
                {
                    "exact_snippets": "Participant (or legally acceptable representative if applicable) provides written informed consent for the trial",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "form",
                            "expected_value": "written"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Participants must be planned or scheduled by their treating physician to receive PD-1 therapy or PD-1 plus anti CTLA-4 therapy as standard of care",
            "criterions": [
                {
                    "exact_snippets": "planned or scheduled by their treating physician to receive PD-1 therapy",
                    "criterion": "PD-1 therapy",
                    "requirements": [
                        {
                            "requirement_type": "planned_or_scheduled",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "prescriber",
                            "expected_value": "treating physician"
                        },
                        {
                            "requirement_type": "purpose",
                            "expected_value": "standard of care"
                        }
                    ]
                },
                {
                    "exact_snippets": "planned or scheduled by their treating physician to receive ... PD-1 plus anti CTLA-4 therapy as standard of care",
                    "criterion": "PD-1 plus anti CTLA-4 therapy",
                    "requirements": [
                        {
                            "requirement_type": "planned_or_scheduled",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "prescriber",
                            "expected_value": "treating physician"
                        },
                        {
                            "requirement_type": "purpose",
                            "expected_value": "standard of care"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Adequate organ function as defined below. Standard of care labs drawn within 45 days prior to consent may be used for the purposes of determining eligibility",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function as defined below",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Participant must have at least 1 lesion that is at least 8 mm in size and is cutaneous, subcutaneous, palpable, or amenable to ultrasound guided core biopsy. The lesion chosen for biopsy can also be a target lesion but does not have to be a target lesion",
            "criterions": [
                {
                    "exact_snippets": "at least 1 lesion",
                    "criterion": "number of lesions",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 1 lesion that is at least 8 mm in size",
                    "criterion": "lesion size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "mm"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "lesion that is ... cutaneous, subcutaneous, palpable, or amenable to ultrasound guided core biopsy",
                    "criterion": "lesion characteristics",
                    "requirements": [
                        {
                            "requirement_type": "location/type",
                            "expected_value": [
                                "cutaneous",
                                "subcutaneous"
                            ]
                        },
                        {
                            "requirement_type": "palpability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "amenable to ultrasound guided core biopsy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. ANC >/= 1500/uL",
            "criterions": [
                {
                    "exact_snippets": "ANC >/= 1500/uL",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "uL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. platelets >/=100,000/uL",
            "criterions": [
                {
                    "exact_snippets": "platelets >/=100,000/uL",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "uL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Hemoglobin >/= 9.0 g/dL",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin >/= 9.0 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9.0,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Male or female participants who are at least 18 years of age on the day of signing informed consent",
            "criterions": [
                {
                    "exact_snippets": "Male or female participants",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum_age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "on the day of signing informed consent",
                    "criterion": "age reference date",
                    "requirements": [
                        {
                            "requirement_type": "reference_date",
                            "expected_value": "day of signing informed consent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "12. Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial",
            "criterions": [
                {
                    "exact_snippets": "Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial",
                    "criterion": "psychiatric disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "interference with trial cooperation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial",
                    "criterion": "substance abuse disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "interference with trial cooperation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with subject's participation for the full duration of the study, or make it not in the best interest of the subject to participate, in the opinion of the treating physician",
            "criterions": [
                {
                    "exact_snippets": "History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study",
                    "criterion": "condition, therapy, or laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "potential to confound study results",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History or current evidence of any condition, therapy, or laboratory abnormality that might ... interfere with subject's participation for the full duration of the study",
                    "criterion": "condition, therapy, or laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "potential to interfere with participation for full duration",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History or current evidence of any condition, therapy, or laboratory abnormality that might ... make it not in the best interest of the subject to participate, in the opinion of the treating physician",
                    "criterion": "condition, therapy, or laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "not in best interest to participate (per treating physician)",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Active infection requiring systemic therapy",
            "criterions": [
                {
                    "exact_snippets": "Active infection requiring systemic therapy",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "requiring systemic therapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Known history of active TB (Bacillus Tuberculosis)",
            "criterions": [
                {
                    "exact_snippets": "Known history of active TB (Bacillus Tuberculosis)",
                    "criterion": "active tuberculosis (TB) history",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patients with symptomatic CNS metastases and/or carcinomatous meningitis",
            "criterions": [
                {
                    "exact_snippets": "symptomatic CNS metastases",
                    "criterion": "CNS metastases",
                    "requirements": [
                        {
                            "requirement_type": "symptom presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "carcinomatous meningitis",
                    "criterion": "carcinomatous meningitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. History of allogenic tissue or solid organ transplant",
            "criterions": [
                {
                    "exact_snippets": "History of allogenic tissue or solid organ transplant",
                    "criterion": "allogenic tissue transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of allogenic tissue or solid organ transplant",
                    "criterion": "solid organ transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Uveal or mucosal melanoma",
            "criterions": [
                {
                    "exact_snippets": "Uveal or mucosal melanoma",
                    "criterion": "melanoma type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "uveal",
                                "mucosal"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Any prior systemic therapy for metastatic melanoma (prior surgery is allowed)",
            "criterions": [
                {
                    "exact_snippets": "Any prior systemic therapy for metastatic melanoma",
                    "criterion": "prior systemic therapy for metastatic melanoma",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "prior surgery is allowed",
                    "criterion": "prior surgery",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. History of or active (non-infectious) pneumonitis that required steroids",
            "criterions": [
                {
                    "exact_snippets": "History of or active (non-infectious) pneumonitis",
                    "criterion": "pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "history_or_active_status",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "infectious_status",
                            "expected_value": "non-infectious"
                        }
                    ]
                },
                {
                    "exact_snippets": "pneumonitis that required steroids",
                    "criterion": "pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "treatment_required",
                            "expected_value": "steroids"
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. History of allergic reaction to IPOL or Td vaccine",
            "criterions": [
                {
                    "exact_snippets": "History of allergic reaction to IPOL",
                    "criterion": "allergic reaction to IPOL vaccine",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of allergic reaction to ... Td vaccine",
                    "criterion": "allergic reaction to Td vaccine",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "15. Receipt of Td vaccine within 30 days prior to starting IO therapy",
            "criterions": [
                {
                    "exact_snippets": "Receipt of Td vaccine within 30 days prior to starting IO therapy",
                    "criterion": "Td vaccine receipt",
                    "requirements": [
                        {
                            "requirement_type": "time since receipt",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to starting IO therapy"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Known history of Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV RNA [qualitative] is detected) infection. NOTE: no testing for Hepatitis B or Hepatitis C is required",
            "criterions": [
                {
                    "exact_snippets": "Known history of Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive)",
                    "criterion": "Hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "HBsAg reactivity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known active Hepatitis C virus (defined as HCV RNA [qualitative] is detected) infection",
                    "criterion": "active Hepatitis C virus infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "HCV RNA [qualitative] is detected",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "a) Patients with asymptomatic, stable CNS metastases are allowed provided that they are not on >10mg prednisone daily",
            "criterions": [
                {
                    "exact_snippets": "Patients with asymptomatic, stable CNS metastases are allowed",
                    "criterion": "CNS metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "asymptomatic"
                        },
                        {
                            "requirement_type": "stability",
                            "expected_value": "stable"
                        }
                    ]
                },
                {
                    "exact_snippets": "provided that they are not on >10mg prednisone daily",
                    "criterion": "prednisone use",
                    "requirements": [
                        {
                            "requirement_type": "dosage",
                            "expected_value": {
                                "operator": "<=",
                                "value": 10,
                                "unit": "mg/day"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Any women known to be pregnant or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "women known to be pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "breastfeeding",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Known diagnosis of immunodeficiency or receiving chronic systemic steroid therapy (in doses exceeding 10 mg daily of prednisone or equivalent), or any other form of immunosuppressive therapy within 7 days prior to first research biopsy",
            "criterions": [
                {
                    "exact_snippets": "Known diagnosis of immunodeficiency",
                    "criterion": "immunodeficiency",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "receiving chronic systemic steroid therapy (in doses exceeding 10 mg daily of prednisone or equivalent)",
                    "criterion": "systemic steroid therapy",
                    "requirements": [
                        {
                            "requirement_type": "chronic use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "dose",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg daily of prednisone or equivalent"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "any other form of immunosuppressive therapy within 7 days prior to first research biopsy",
                    "criterion": "immunosuppressive therapy",
                    "requirements": [
                        {
                            "requirement_type": "use within days prior to first research biopsy",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Known history of Human Immunodeficiency Virus (HIV) infection",
            "criterions": [
                {
                    "exact_snippets": "Known history of Human Immunodeficiency Virus (HIV) infection",
                    "criterion": "Human Immunodeficiency Virus (HIV) infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}